Skip to main content
. 2017 Nov 4;33(2):448–460. doi: 10.1007/s12640-017-9835-5

Table 1.

Sociodemographic, clinical, and biomarker data in patients with treatment-resistant depression (TRD), non-TRD, and healthy controls (HC)

Variables HCA (n = 50) Non-TRDB (n = 72) TRDC (n = 42) F/O2 df p
Age (years) 45.8 (12.4) 48.9 (11.9) 50.2 (8.5) 1.89 2/131 0.155
Gender (F/M) 34/14 42/30 31/11 3.84 2 0.147
Marital status* 18/29 17/55 7/33 5.34 2 0.069
Nicotine dependence (N/Y) 47/3 38/33 21/21 26.76 2 < 0.001
IL-1α (pg/mL) 2.7 (2.4) 2.3 (1.8) 4.9 (10.8) 0.31 2/155 0.732
IL-1RA (ng/mL) 3.30 (2.45)B, C 5.30 (3.94) A 5.23 (3.17)A 5.61 2/155 0.004
IL-2R (pg/mL) 783 (385) 919 (458) 829 (298) 1.19 2/157 0.308
IL-6R (ng/mL) 26.6 (9.4) 25.8 (6.3) 36.3 (34.8) 2.95 2/150 0.056
sTNF-R1 (ng/mL) 0.18 (0.07) 0.20 (0.006) 0.23 (0.22) 1.71 2/143 0.184
sTNF-R2 (ng/mL) 1.01 (1.32) 0.98 (0.99)C 0.84 (1.55)B 4.03 2/139 0.020
TBARS (nmol/mL) 2.37 (1.10) B,C 3.18 (1.22)A, C 3.86 (1.42)A,B 15.34 2/154 < 0.001
HDRS 12.2 (8.5) 14.3 (9.7) 1.40 1/112 0.239
MADRS 16.5 (13.2) 19.2 (13.7) 1.06 1/112 0.305
Age at onset (years) 35.5 (12.7) 37.2 (11.0) 0.53 1/110 0.466
Number episodes 5.6 (4.2) 6.0 (4.5) 0.53 1/107 0.612
Melancholia (no/yes) 49/22 25/15 0.49 1 0.485
Atypical MDD (no/yes) 62/10 29/11 3.13 1 0.087
Current MDD (no/yes) 40/29 32/13 2.02 1 0.155

Data are shown as mean (standard deviation; SD). Superscript A, B, C show the significant (p = 0.05) pairwise differences among the three study samples

IL-1α interleukin-1 alpha, sIL-1RA soluble interleukin 1 receptor antagonist, sIL-2R soluble interleukin 2 receptor, sIL-6R soluble interleukin 6 receptor, sTNF-R1/R2 soluble tumor necrosis factor receptor 60 kDa/80 kDa, TBARS thiobarbituric acid reactive substances

*Marital status: stable relationship + married / single + divorced